Prostate cancer spheroids vastly co-express stemness (CD44v9+ EpCAM+ CD133+ ESRP1/2+), epithelial (E-cadherin+), and mesenchymal (Vimentin+) markers, and markedly release EpCAM+ CD9+ EVs [10]. Here, EPCAM is linked to prostate cancer.